Mansky LM - Search Results

1

5-Azacytidine Enhances the Mutagenesis of HIV-1 by Reduction to 5-Aza-2'-Deoxycytidine.

Rawson JM, Daly MB, Xie J, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM. Rawson JM, et al. Among authors: mansky lm. Antimicrob Agents Chemother. 2016 Mar 25;60(4):2318-25. doi: 10.1128/AAC.03084-15. Print 2016 Apr. Antimicrob Agents Chemother. 2016. PMID: 26833151 Free PMC article.

2

HIV mutagenesis and the evolution of antiretroviral drug resistance.

Mansky LM. Mansky LM. Drug Resist Updat. 2002 Dec;5(6):219-23. doi: 10.1016/s1368-7646(02)00118-8. Drug Resist Updat. 2002. PMID: 12531178 Review.

3

Nucleoside reverse transcriptase inhibitors and HIV mutagenesis.

Jewell NA, Chen R, Raices R, Mansky LM. Jewell NA, et al. Among authors: mansky lm. J Antimicrob Chemother. 2003 Oct;52(4):547-50. doi: 10.1093/jac/dkg387. Epub 2003 Sep 1. J Antimicrob Chemother. 2003. PMID: 12951341 Review. No abstract available.

4

A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis.

Weiss KK, Chen R, Skasko M, Reynolds HM, Lee K, Bambara RA, Mansky LM, Kim B. Weiss KK, et al. Among authors: mansky lm. Biochemistry. 2004 Apr 20;43(15):4490-500. doi: 10.1021/bi035258r. Biochemistry. 2004. PMID: 15078095

5

Drug resistance, virus fitness and HIV-1 mutagenesis.

Chen R, Quinones-Mateu ME, Mansky LM. Chen R, et al. Among authors: mansky lm. Curr Pharm Des. 2004;10(32):4065-70. doi: 10.2174/1381612043382404. Curr Pharm Des. 2004. PMID: 15579088 Review.

6

Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.

Chen R, Yokoyama M, Sato H, Reilly C, Mansky LM. Chen R, et al. Among authors: mansky lm. J Virol. 2005 Sep;79(18):12045-57. doi: 10.1128/JVI.79.18.12045-12057.2005. J Virol. 2005. PMID: 16140780 Free PMC article.

7

5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1.

Dapp MJ, Clouser CL, Patterson S, Mansky LM. Dapp MJ, et al. Among authors: mansky lm. J Virol. 2009 Nov;83(22):11950-8. doi: 10.1128/JVI.01406-09. Epub 2009 Sep 2. J Virol. 2009. PMID: 19726509 Free PMC article.

8

Exploiting drug repositioning for discovery of a novel HIV combination therapy.

Clouser CL, Patterson SE, Mansky LM. Clouser CL, et al. Among authors: mansky lm. J Virol. 2010 Sep;84(18):9301-9. doi: 10.1128/JVI.01006-10. Epub 2010 Jul 7. J Virol. 2010. PMID: 20610712 Free PMC article.

9

Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometry.

Grigsby IF, Zhang W, Johnson JL, Fogarty KH, Chen Y, Rawson JM, Crosby AJ, Mueller JD, Mansky LM. Grigsby IF, et al. Among authors: mansky lm. Retrovirology. 2010 Sep 20;7:75. doi: 10.1186/1742-4690-7-75. Retrovirology. 2010. PMID: 20854688 Free PMC article.

10

Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms.

Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, Park IH, Kaufman DS. Ni Z, et al. Among authors: mansky lm. J Virol. 2011 Jan;85(1):43-50. doi: 10.1128/JVI.01774-10. Epub 2010 Oct 20. J Virol. 2011. PMID: 20962093 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page